Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 7c; Initiates Talks with Japan for Voclosporin Phase 1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: AUPH) | Delayed: 16.86 -0.47 (2.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.33 | 52 Week High | $5.69 | |||
| Open | $17.27 | 52 Week Low | $1.42 | |||
| Day High | $17.31 | P/E | N/A | |||
| Day Low | $16.81 | EPS | $0.00 | |||
| Volume | 649,243 | |||||
